Costco Sells Discounted Ozempic, Wegovy
Analysis based on 9 articles · First reported Oct 03, 2025 · Last updated Oct 06, 2025
The partnership between Costco and Novo Nordisk is expected to positively impact both companies. Costco's move into discounted GLP-1 medications like Semaglutide and Semaglutide could attract new members and increase pharmacy sales, while Novo Nordisk benefits from expanded distribution and increased accessibility for its key products, potentially boosting revenue and market share. This also sets a competitive precedent for other retailers like Lewis Pharmacy, Walgreens, and Walmart.
Costco has partnered with Novo Nordisk to offer popular weight-loss and diabetes drugs, Semaglutide and Semaglutide, at a discounted price of $499 for a four-week supply through its pharmacies. This initiative, available to Costco members not using insurance, aims to improve access to these medications, which typically retail for much higher prices. The move is seen as a way to combat the high cost and limited insurance coverage that many Americans face when trying to obtain GLP-1 medications. David Moore of Novo Nordisk emphasized the importance of offering authentic medications through a trusted brand like Costco. While experts like Rekha Kumar and Harlan Krumholz acknowledge the improved access, they also highlight that the $499 price may still be prohibitive for lower socioeconomic strata and does not resolve broader issues of insurance coverage.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard